Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio’s (NASDAQ: RLYB) full interest in their joint ...

Handpicked titles for beginner to senior-level software rolesCovers coding, system design, clean code, and real-world problem ...

Alpha Evolve exemplifies the fantastic potential of recursive AI systems. Through iterative self-improvement, it has achieved breakthroughs in computational efficiency, hardware design, and ...

Valence is a pioneer in low-data small molecule drug design which Recursion bought for $47.5 million last year. ... An NVIDIA DGX SuperPOD based system called Eos ranks No. 10 among supercomputers ...

Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets.KYIV, Ukraine and SALT LAKE CITY, Dec. 20 ...